Stockreport

Lisata Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update [Yahoo! Finance]

Lisata Therapeutics, Inc.  (LSTA) 
PDF Enrollment completed in Qilu's Phase 2 trial evaluating certepetide for the treatment of first-line mPDAC Advancing development portfolio with multiple milestones pro [Read more]